FDA Approves Expanded Use of CRESEMBA® (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis
-
Drug News
FDA Approves Expanded Use of CRESEMBA® (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis
The U.S. Food and Drug Administration (FDA) has granted approval for the expanded use of CRESEMBA® (isavuconazonium sulfate), an azole…
Read More »
